Active substance
Bleomycin
- SFDA 3
- US FDA 9
- Health Canada 2
- US price lines 1
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Bleoez | 15 IU | powder for solution for injection · Intravenous, Intramuscular, Subcutaneous | 1 Vial | SAR 67.90 | Generic · Prescription | Korea United Pharm. Inc | Valid |
| Bleomycin Venus | 15 USP Units | Powder for solution for injection/infusion · Intramuscular and intravenous use | 1 Vial | SAR 63.05 | Generic · Prescription | VENUS REMEDIES LIMITED | Valid |
| BLEOCIN 15MG VIAL | 15 mg | Solution · Intravenous use | 1 Vial | SAR 72.75 | NCE · Prescription | NIPPON KAYAKU | Invalid · Not Marketed |
Indications — CHI Daman Drug Formulary
BURN MANAGEMENT
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| BLEOMYCIN SULFATE | EQ 15 UNITS BASE/VIAL; EQ 30 UNITS BASE/VIAL | injectable · injection | HOSPIRA | Prescription | 10 Mar 2000 |
| BLEOMYCIN SULFATE | EQ 30 UNITS BASE/VIAL; EQ 15 UNITS BASE/VIAL | injectable · injection | HIKMA PHARMS | Prescription | 17 Oct 2001 |
| BLEOMYCIN SULFATE | EQ 15 UNITS BASE/VIAL; EQ 30 UNITS BASE/VIAL | injectable · injection | FRESENIUS KABI USA | Prescription | 28 Jan 2008 |
| BLEOMYCIN SULFATE | EQ 15 UNITS BASE/VIAL; EQ 30 UNITS BASE/VIAL | injectable · injection | MEITHEAL | Prescription | 20 Apr 2018 |
| BLENOXANE | EQ 15 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 30 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | BRISTOL MYERS SQUIBB | Discontinued | 31 Jul 1973 |
| BLEOMYCIN SULFATE | EQ 15 UNITS BASE/VIAL; EQ 30 UNITS BASE/VIAL | injectable · injection | TEVA PARENTERAL | Discontinued | 3 Jun 1996 |
| BLEOMYCIN SULFATE | EQ 15 UNITS BASE/VIAL; EQ 30 UNITS BASE/VIAL | injectable · injection | TEVA PHARMS USA | Discontinued | 27 Jun 2000 |
| BLEOMYCIN SULFATE | EQ 15 UNITS BASE/VIAL | injectable · injection | PHARMACHEMIE BV | Discontinued | 13 Dec 2007 |
| BLEOMYCIN SULFATE | EQ 15 UNITS BASE/VIAL | injectable · injection | CIPLA | Discontinued | 11 Mar 2019 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| BLEOMYCIN FOR INJECTION | 02265982 | 15 UNIT / VIAL | POWDER FOR SOLUTION · INTRAPLEURAL; SUBCUTANEOUS; INTRAMUSCULAR; INTRAVENOUS | FRESENIUS KABI CANADA LTD |
| BLEOMYCIN FOR INJECTION USP | 02131692 | 15 UNIT / VIAL | POWDER FOR SOLUTION · SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; INTRA-ARTERIAL; INTRACAVITARY | PFIZER CANADA ULC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | BLEOMYCIN SULFATE 15 UNIT VIAL | $26.448 | per EA | 22 Apr 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 8.2.1. Cytotoxic medicines · complementary
Kaposi sarcoma of unspecified primary site; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Hodgkin lymphoma
Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate)
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.